FDA Adverse Event Injury Summary report: N

NATRELLE SILICONE-FILLED BREAST IMPLANT

MDR report key: 19557989 · Received June 17, 2024

Report

Report Number
MW5156318
Event Type
Injury
Date Received
June 17, 2024
Date of Event
August 17, 2021
Report Date
June 12, 2024
Manufacturer
ALLERGAN SALES, LLC.
Product Code
FTR
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
GA, US
Reporter Occupation
PATIENT
Health Professional
*

Narratives

Description of Event or Problem · 0

IN (B)(6) OF 2021, I BEGAN SEEING A RHEUMATOLOGIST DUE TO INCREASING SYMPTOMS OF FATIGUE AND PAIN IN MY BODY. THEY HAVE RUN MANY TESTS AND MY INFLAMMATION MARKERS ARE STAYING HIGH BUT NO DIAGNOSES OF RA OR ANY OTHER AUTOIMMUNE DISORDER TESTED POSITIVE. THEY DIAGNOSED ME WITH FIBROMYALGIA BUT MY SYMPTOMS OF JOINT PAIN ARE STEADILY INCREASING. I HAVE ALLERGAN BREAST IMPLANTS IMPLANTED IN 2016 WHICH WERE RECALLED IN 2019 BUT MY PLASTIC SURGEON HAS SAID MULTIPLE TIMES THAT I DID NOT HAVE SIGNS OF CANCER AND DID NOT NEED TO REMOVE THE EXPANDER AND THAT ALLERGAN WOULD NOT PAY FOR THE REMOVAL WHICH WAS A FINANCIAL ISSUE FOR MY FAMILY. I RECEIVED THE EXPANDER DUE TO BEING BORN WITH A DEFORMITY, TUBULAR BREAST'S, AND WAS CORRECTING THE DEFORMITY. I FEEL LIKE I AM SUFFERING FROM BII. (BREAST IMPLANT ILLNESS). THESE BLOOD WORK TEST WENT ON FOR ALMOST 2 YEARS. REFERENCE REPORTS: MW5156317, MW5156319, MW5156320.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1655669 NATRELLE SILICONE-FILLED BREAST IMPLANT PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED FTR ALLERGAN SALES, LLC. 120-500

Patients

Seq Age Sex Outcome Treatment
1 34 YR Female Disability CPAP (CONTINUOUS POSITIVE AIRWAY PRESSURE)| MULTI VITAMIN| TISSUE EXPANDERS